{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:37:42Z","timestamp":1780529862987,"version":"3.54.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/25\/2013-NAN-BMS"],"award-info":[{"award-number":["45\/25\/2013-NAN-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ijbiomac.2018.04.122","type":"journal-article","created":{"date-parts":[[2018,4,30]],"date-time":"2018-04-30T09:16:17Z","timestamp":1525079777000},"page":"648-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"C","title":["Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies"],"prefix":"10.1016","volume":"116","author":[{"given":"Nazia","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Ameeduzzafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kushagra","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseem","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan Jalees","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.sjopt.2015.02.003","article-title":"Efficacy and safety of 1% forskolin eye drops in open angle glaucoma\u2013An open label study","volume":"29","author":"Majeed","year":"2015","journal-title":"Saudi J. Ophthalmol."},{"issue":"18","key":"10.1016\/j.ijbiomac.2018.04.122_bb0010","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12886-016-0220-6","article-title":"Glaucoma,\u201cthe silent thief of sight\u201d: patients' perspectives and health seeking behaviour in Bauchi, northern Nigeria","volume":"16","author":"Abdull","year":"2016","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.colsurfb.2014.07.004","article-title":"Dorzolamide-loaded PLGA\/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits","volume":"122","author":"Warsi","year":"2014","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0030","first-page":"268","article-title":"Forskolin lowers intraocular pressure by reducing aqueous inflow","volume":"25","author":"Caprioli","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/0022-3859.101396","article-title":"Forskolin: upcoming antiglaucoma molecule","volume":"58","author":"Wagh","year":"2012","journal-title":"J. Postgrad. Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.04.122_bb0040","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0014-4835(84)90073-3","article-title":"Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator","volume":"39","author":"Burstein","year":"1984","journal-title":"Exp. Eye Res."},{"issue":"35","key":"10.1016\/j.ijbiomac.2018.04.122_bb0045","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.2174\/0929867322666151001121601","article-title":"Non-viral delivery systems for the application in p53 cancer gene therapy","volume":"22","author":"Wang","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1155\/2013\/170201","article-title":"Polymeric nanosuspensions for enhanced dissolution of water insoluble drugs","volume":"2013","author":"Yadollahi","year":"2013","journal-title":"J. Nanomater."},{"issue":"9","key":"10.1016\/j.ijbiomac.2018.04.122_bb0055","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/acs.biomac.7b00760","article-title":"Sustained release of a peptide-based matrix metalloproteinase-2 inhibitor to attenuate adverse cardiac remodeling and improve cardiac function following myocardial infarction","volume":"18","author":"Fan","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0060","first-page":"65","article-title":"Biodegradable polymers for ocular drug delivery","volume":"2012","author":"Tamboli","year":"2012","journal-title":"Adv. Ocul. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0065","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s41598-018-19906-w","article-title":"An injectable oxygen release system to augment cell survival and promote cardiac repair following myocardial infarction","volume":"8","author":"Fan","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0070","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0075","series-title":"Charge-Reversal Polymers for Biodelivery","first-page":"223","author":"Zhang","year":"2014"},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.nano.2007.03.006","article-title":"Chitosan-coated PLGA nanoparticles for DNA\/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides","volume":"3","author":"Nafee","year":"2007","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-3659(01)00486-2","article-title":"Design of biodegradable particles for protein delivery","volume":"78","author":"Vila","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0090","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ijbiomac.2016.02.033","article-title":"Optimizing indomethacin-loaded chitosan nanoparticle size, encapsulation, and release using Box\u2013Behnken experimental design","volume":"87","author":"Kalam","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2018.04.122_bb0095","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1021\/acs.jchemed.5b00837","article-title":"Preparation and Characterization of Polymeric Nanoparticles: An Interdisciplinary Experiment","volume":"93","author":"Ramalho","year":"2016","journal-title":"J. Chem. Educ."},{"issue":"10","key":"10.1016\/j.ijbiomac.2018.04.122_bb0100","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.biomaterials.2003.08.069","article-title":"Preparation and characterization of cationic PLGA nanospheres as DNA carriers","volume":"25","author":"Kumar","year":"2004","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0105","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1556\/JPC.26.2013.1.13","article-title":"Ali, Stability-indicating HPTLC method of carteolol in bulk drug and in pharmaceutical dosage forms","volume":"26","author":"Ameeduzzafar","year":"2013","journal-title":"JPC J. Planar Chromatogr. - Mod. TLC"},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0110","doi-asserted-by":"crossref","first-page":"S2969","DOI":"10.1016\/j.arabjc.2013.11.034","article-title":"Ali, Development and validation of UPLC\/ESI-Q-TOF-MS for carteolol in aqueous humour: Stability, stress degradation and application in pharmacokinetics of nanoformulation","volume":"10","author":"Ameeduzzafar","year":"2017","journal-title":"Arab. J. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2018.04.122_bb0115","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s11095-010-0103-0","article-title":"The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery","volume":"27","author":"Yuan","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0120","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2017.07.110","article-title":"Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes","volume":"94","author":"Kalam","year":"2017","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40199-014-0087-0","article-title":"Formulation and optimization of itraconazole polymeric lipid hybrid nanoparticles (Lipomer) using box behnken design","volume":"23","author":"Gajra","year":"2015","journal-title":"DARU J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.04.122_bb0130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/02652048.2011.580861","article-title":"Formulation and optimization of alkaline extracted ispaghula husk microparticles of isoniazid\u2013in vitro and in vivo assessment","volume":"28","author":"Maurya","year":"2011","journal-title":"J. Microencapsul."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.04.122_bb0135","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1208\/s12249-010-9413-0","article-title":"In situ gelling gelrite\/alginate formulations as vehicles for ophthalmic drug delivery","volume":"11","author":"Liu","year":"2010","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0140","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT080301P6","article-title":"Dissolution method development for poorly soluble compounds","volume":"8","author":"Rohrs","year":"2001","journal-title":"Dissolut. Technol."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.molliq.2017.07.002","article-title":"Design expert assisted nanoformulation design for co-delivery of topotecan and thymoquinone: optimization, in vitro characterization and stability assessment","volume":"242","author":"Verma","year":"2017","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0150","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clay.2015.10.028","article-title":"Preparation and in vitro study of lipid nanoparticles encapsulating drug loaded montmorillonite for ocular delivery","volume":"119","author":"Hou","year":"2016","journal-title":"Appl. Clay Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.04.122_bb0155","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1208\/s12249-013-9943-3","article-title":"Chitosan-modified PLGA nanoparticles with versatile surface for improved drug delivery","volume":"14","author":"Wang","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0160","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijbiomac.2014.02.002","article-title":"Ali, Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits","volume":"65","author":"Ameeduzzafar","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2018.04.122_bb0165","first-page":"941","article-title":"In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops","volume":"35","author":"Malhotra","year":"1997","journal-title":"Indian J. Exp. Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.04.122_bb0170","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1080\/21691401.2016.1203794","article-title":"PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study","volume":"45","author":"Sah","year":"2017","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2018.04.122_bb0175","first-page":"322","article-title":"Design and development of novel bioadhesive niosomal formulation for the transcorneal delivery of anti-infective agent: in-vitro and ex-vivo investigations","volume":"10","author":"Zubairu","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.04.122_bb0180","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.colsurfb.2010.09.010","article-title":"Microscopic and spectroscopic evaluation of novel PLGA\u2013chitosan nanoplexes as an ocular delivery system","volume":"82","author":"Jain","year":"2011","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"7","key":"10.1016\/j.ijbiomac.2018.04.122_bb0185","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/21691401.2016.1243545","article-title":"Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation","volume":"45","author":"Pandit","year":"2017","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1556\/avet.58.2010.3.9","article-title":"HET-CAM test for determining the possible eye irritancy of pesticides","volume":"58","author":"Budai","year":"2010","journal-title":"Acta Vet. Hung."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0195","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2012.04.060","article-title":"Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies","volume":"432","author":"Bhatta","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.04.122_bb0200","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.nano.2009.10.004","article-title":"Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery","volume":"6","author":"Gupta","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1586\/14737175.2015.1036743","article-title":"Nano-ropinirole for the management of Parkinsonism: blood\u2013brain pharmacokinetics and carrier localization","volume":"6","author":"Mustafa","year":"2015","journal-title":"Expert. Rev. Neurother."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.04.122_bb0210","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1006\/exer.2001.1087","article-title":"Ocular hypotensive and aqueous outflow-enhancing effects of AL-3037A (sodium ferri ethylenediaminetetraacetate)","volume":"73","author":"Pang","year":"2001","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5173(00)00539-1","article-title":"A new long acting ophthalmic formulation of carteolol containing alginic acid","volume":"207","author":"Sechoy","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0220","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.colsurfb.2012.08.038","article-title":"Nanocarrier based formulation of Thymoquinone improves oral delivery: stability assessment, in vitro and in vivo studies","volume":"102","author":"Singh","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0225","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.carbpol.2011.03.045","article-title":"Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends","volume":"85","author":"Li","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0230","doi-asserted-by":"crossref","first-page":"11337","DOI":"10.1038\/srep11337","article-title":"Chitosan grafted methoxy poly (ethylene glycol)-poly (\u03b5-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac","volume":"5","author":"Shi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnmrs.2014.01.002","article-title":"Progress in the characterization of bio-functionalized nanoparticles using NMR methods and their applications as MRI contrast agents","volume":"79","author":"L\u00f3pez-Cebral","year":"2014","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"issue":"13","key":"10.1016\/j.ijbiomac.2018.04.122_bb0240","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1021\/la050569j","article-title":"High-resolution 2D 1H\u2212 15N NMR characterization of persistent structural alterations of proteins induced by interactions with silica nanoparticles","volume":"21","author":"Lundqvist","year":"2005","journal-title":"Langmuir"},{"issue":"2","key":"10.1016\/j.ijbiomac.2018.04.122_bb0245","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11051-015-2875-y","article-title":"Comparative study of chitosan-and PEG-coated lipid and PLGA nanoparticles as oral delivery systems for cannabinoids","volume":"17","author":"Dur\u00e1n-Lobato","year":"2015","journal-title":"J. Nanopart. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/ejnm-2013-0012","article-title":"Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits","volume":"5","author":"Akhter","year":"2013","journal-title":"Eur. J. Nanomed."},{"issue":"11","key":"10.1016\/j.ijbiomac.2018.04.122_bb0255","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1248\/cpb.52.1273","article-title":"Influence of the homogenisation procedure on the physicochemical properties of PLGA nanoparticles","volume":"52","author":"Vandervoort","year":"2004","journal-title":"Chem. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.ijbiomac.2018.04.122_bb0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2004.11.027","article-title":"PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution","volume":"290","author":"Mainardes","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2018.04.122_bb0265","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/10717540701202937","article-title":"Effect of conditions of preparation on the size and encapsulation properties of PLGA-mPEG nanoparticles of cisplatin","volume":"14","author":"Gryparis","year":"2007","journal-title":"Drug Deliv."},{"issue":"12","key":"10.1016\/j.ijbiomac.2018.04.122_bb0270","doi-asserted-by":"crossref","first-page":"23909","DOI":"10.3390\/ijms151223909","article-title":"PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release","volume":"15","author":"Halayqa","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2018.04.122_bb0275","first-page":"404","article-title":"Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study","volume":"11","author":"Sharma","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2018.04.122_bb0280","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1023\/A:1011929016601","article-title":"Chitosan and its use as a pharmaceutical excipient","volume":"15","author":"Ilium","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2018.04.122_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/3810175","article-title":"Poly (lactic-co-glycolic) acid-chitosan dual loaded nanoparticles for antiretroviral nanoformulations","volume":"2016","author":"Makita-Chingombe","year":"2016","journal-title":"J. Drug Deliv."},{"issue":"4","key":"10.1016\/j.ijbiomac.2018.04.122_bb0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics9040053","article-title":"An overview of chitosan nanoparticles and its application in non-parenteral drug delivery","volume":"9","author":"Mohammed","year":"2017","journal-title":"Pharmaceutics"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018306068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813018306068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T07:10:29Z","timestamp":1758870629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813018306068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":58,"alternative-id":["S0141813018306068"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.04.122","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2018.04.122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}